Normal view MARC view ISBD view

Delivery of affordable and equitable cancer care in India

In The Lancet Oncology
Contributor(s): Sullivan R | Purushotham A | Aggarwal A | Vijaykumar DK | Vijayakumar M | Shukla S | Sharma SC | Shanta V | Sarin R | Sebastian P | Sagar TG | Rath GK | Nayak S | Malhotra H | Kapoor S | Kalwar A | Kannan T | Raj EH | Chandra M | Borthakur BB | Badwe RA | prameshcs@tmc.gov.in | Pramesh CS.
Material type: materialTypeLabelArticleSeries: Vol 14 Issues.Publisher: 2014Description: 1-11.Subject(s): Public expenditure | Public health challenges | India | Cancer Care | DDC classification: In: The Lancet OncologySummary: The delivery of affordable and equitable cancer care is one of India's greatest public health challenges. Public expenditure on cancer in India remains below US$10 per person (compared with more than US$100 per person in high-income countries), and overall public expenditure on health care is still only slightly above 1% of gross domestic product. Out-of-pocket payments, which account for more than three-quarters of cancer expenditures in India, are one of the greatest threats to patients and families, and a cancer diagnosis is increasingly responsible for catastrophic expenditures that negatively affect not only the patient but also the welfare and education of several generations of their family. We explore the complex nature of cancer care systems across India, from state to government levels, and address the crucial issues of infrastructure, manpower shortages, and the pressing need to develop cross-state solutions to prevention and early detection of cancer, in addition to governance of the largely unr
Tags from this library: No tags from this library for this title. Add tag(s)
Log in to add tags.
    average rating: 0.0 (0 votes)
Item type Current location Call number Status Date due Barcode
Articles Articles Tata Memorial Hospital
(Browse shelf) Available AR14840

The delivery of affordable and equitable cancer care is one of India's greatest public health challenges. Public expenditure on cancer in India remains below US$10 per person (compared with more than US$100 per person in high-income countries), and overall public expenditure on health care is still only slightly above 1% of gross domestic product. Out-of-pocket payments, which account for more than three-quarters of cancer expenditures in India, are one of the greatest threats to patients and families, and a cancer diagnosis is increasingly responsible for catastrophic expenditures that negatively affect not only the patient but also the welfare and education of several generations of their family. We explore the complex nature of cancer care systems across India, from state to government levels, and address the crucial issues of infrastructure, manpower shortages, and the pressing need to develop cross-state solutions to prevention and early detection of cancer, in addition to governance of the largely unr

There are no comments for this item.

Log in to your account to post a comment.

Powered by Koha